PINK:DTCFF

Defence Therapeutics Stock Forecast

etoro logo Buy DTCFF
*Your capital is at risk
$0.299
+0.0178 (+6.31%)
At Close: Jul 31, 2026
AI Analysis AI Analysis of DTCFF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add DTCFF to Watchlist?
  • Easy Tracking In The Watchlist
PDF

A very strong day for Defence Therapeutics Inc stock price on Friday
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jul 29, 2026 Gain 1.84%

The Defence Therapeutics Inc stock price gained 6.31% on the last trading day (Friday, 31st Jul 2026), rising from $0.281 to $0.299. During the last trading day the stock fluctuated 0% from a day low at $0.299 to a day high of $0.299. The price has risen in 4 of the last 10 days but is still down by -14.57% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 5 thousand more shares were traded than the day before. In total, 5 thousand shares were bought and sold for approximately $1.50 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.79% during the next 3 months and, with a 90% probability hold a price between $0.194 and $0.325 at the end of this 3-month period.

DTCFF Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 22, 2026, and so far it has risen 18.04%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Defence Therapeutics Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Defence Therapeutics Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.321. On a fall, the stock will find some support from the short-term average at $0.286. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Defence Therapeutics Inc stock

Defence Therapeutics Inc finds support from accumulated volume at $0.294 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 0.756%.

Our recommended stop-loss: $0.287 (-4.10%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (DTCFF) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Defence Therapeutics Inc to open at $0.299, and during the day (based on 14 day Average True Range), to move between $0.289 and $0.309, which gives a possible trading interval of +/-$0.0201 (+/-6.96%) up or down from last closing price. If Defence Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 6.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.294 (1.81%) than the resistance at $0.332 (10.89%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Defence Therapeutics Inc stock A Buy?

Defence Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.657 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.299 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

DTCFF Performance

Trading levels for DTCFF

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.299 -
R2 0.299 -
R1 0.299 -
Price 0.299
S1 0.299 -
S2 0.299 -
S3 0.299 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.370 23.75%
R2 0.350 17.06%
R1 0.332 10.89%
Price 0.299
S1 0.294 -1.81%
S2 0.267 -10.70%
S3 0.253 -15.28%

FAQ

What is the symbol for Defence Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Defence Therapeutics Inc is DTCFF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Defence Therapeutics Inc Stock?
Defence Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Defence Therapeutics Inc Stock?
Defence Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Defence Therapeutics Inc Stock.

What's the current price of Defence Therapeutics Inc Stock?
As of the end of day on the Jul 31, 2026, the price of an Defence Therapeutics Inc (DTCFF) share was $0.299.

What is the 52-week high and low for Defence Therapeutics Inc Stock?
The 52-week high for Defence Therapeutics Inc Stock is $0.779 and the 52-week low is $0.253.

What is the market capitalization of Defence Therapeutics Inc Stock?
As of the Jul 31, 2026, the market capitalization of Defence Therapeutics Inc is 22.661M.
Click to get the best stock tips daily for free!
ABOUT DEFENCE THERAPEUTICS INC
Defence Therapeutics
Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biological/biosimilar therapeutic drugs for cancer and infectious diseases. Its proprietary platform is the ACCUMTM technology, which enables precision delivery of vaccine antigens or ADCs in their intact form to target cells. The company focuses on developing dendritic cell cancer vaccines; protein-based vaccine formulation against COVID and infectious...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE